Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Diane 35 plus finasteride is more effective for treating hirsutism.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.